These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31669605)

  • 1. A Comparison Between Emerging and Current Biophysical Methods for the Assessment of Higher-Order Structure of Biopharmaceuticals.
    Wen J; Batabyal D; Knutson N; Lord H; Wikström M
    J Pharm Sci; 2020 Jan; 109(1):247-253. PubMed ID: 31669605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of the 2D
    Hwang TL; Batabyal D; Knutson N; Wikström M
    Molecules; 2021 May; 26(9):. PubMed ID: 34063095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive characterization of higher order structure changes in methionine oxidized monoclonal antibodies via NMR chemometric analysis and biophysical approaches.
    Li M; Beaumont VA; Akbar S; Duncan H; Creasy A; Wang W; Sackett K; Marzilli L; Rouse JC; Kim HY
    MAbs; 2024; 16(1):2292688. PubMed ID: 38117548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing the Utility of Circular Dichroism and FTIR Spectroscopy in Monoclonal-Antibody Comparability Studies.
    Lin JC; Glover ZK; Sreedhara A
    J Pharm Sci; 2015 Dec; 104(12):4459-4466. PubMed ID: 26505267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Automated, High-Throughput Infrared Spectroscopy for Secondary Structure Analysis of Protein Biopharmaceuticals.
    Liu LL; Wang L; Zonderman J; Rouse JC; Kim HY
    J Pharm Sci; 2020 Oct; 109(10):3223-3230. PubMed ID: 32758548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining Spectroscopic Quantitation Limits for Misfolded Structures.
    Kendrick BS; Gabrielson JP; Solsberg CW; Ma E; Wang L
    J Pharm Sci; 2020 Jan; 109(1):933-936. PubMed ID: 31521643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of protein higher order structure using vibrational circular dichroism spectroscopy.
    Nagarkar RP; Murphy BM; Yu X; Manning MC; Al-Azzam WA
    Curr Pharm Biotechnol; 2013; 14(2):199-208. PubMed ID: 23167760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enabling adoption of 2D-NMR for the higher order structure assessment of monoclonal antibody therapeutics.
    Brinson RG; Marino JP; Delaglio F; Arbogast LW; Evans RM; Kearsley A; Gingras G; Ghasriani H; Aubin Y; Pierens GK; Jia X; Mobli M; Grant HG; Keizer DW; Schweimer K; Ståhle J; Widmalm G; Zartler ER; Lawrence CW; Reardon PN; Cort JR; Xu P; Ni F; Yanaka S; Kato K; Parnham SR; Tsao D; Blomgren A; Rundlöf T; Trieloff N; Schmieder P; Ross A; Skidmore K; Chen K; Keire D; Freedberg DI; Suter-Stahel T; Wider G; Ilc G; Plavec J; Bradley SA; Baldisseri DM; Sforça ML; Zeri ACM; Wei JY; Szabo CM; Amezcua CA; Jordan JB; Wikström M
    MAbs; 2019 Jan; 11(1):94-105. PubMed ID: 30570405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Principles and applications of selective biophysical methods for characterization and comparability assessment of a monoclonal antibody.
    Maity H; Lai Y; Srivastava A; Goldstein J
    Curr Pharm Biotechnol; 2012 Aug; 13(10):2078-101. PubMed ID: 22812451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMR based quality evaluation of mAb therapeutics: A proof of concept higher order structure biosimilarity assessment of trastuzumab biosimilars.
    Joshi S; Khatri LR; Kumar A; Rathore AS
    J Pharm Biomed Anal; 2022 May; 214():114710. PubMed ID: 35290923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct biophysical characterization of human apolipoprotein A-1 in ISCOMs.
    Chen H; Sanyal G
    J Pharm Sci; 1999 Nov; 88(11):1122-6. PubMed ID: 10564059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher-Order Structure Characterization of Pharmaceutical Proteins by 2D Nuclear Magnetic Resonance Methyl Fingerprinting.
    Haxholm GW; Petersen BO; Malmstrøm J
    J Pharm Sci; 2019 Sep; 108(9):3029-3035. PubMed ID: 31082403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical characterization of Met-G-CSF: effects of different site-specific mono-pegylations on protein stability and aggregation.
    Natalello A; Ami D; Collini M; D'Alfonso L; Chirico G; Tonon G; Scaramuzza S; Schrepfer R; Doglia SM
    PLoS One; 2012; 7(8):e42511. PubMed ID: 22905140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly concentrated monoclonal antibody solutions: direct analysis of physical structure and thermal stability.
    Harn N; Allan C; Oliver C; Middaugh CR
    J Pharm Sci; 2007 Mar; 96(3):532-46. PubMed ID: 17083094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technical decision-making with higher order structure data: specific binding of a nonionic detergent perturbs higher order structure of a therapeutic monoclonal antibody.
    Budyak IL; Doyle BL; Weiss WF
    J Pharm Sci; 2015 Apr; 104(4):1543-7. PubMed ID: 25545760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Higher Order Structural Changes of a Thermally Stressed Monoclonal Antibody via Mass Spectrometry Footprinting and Other Biophysical Approaches.
    Lin Y; Moyle AB; Beaumont VA; Liu LL; Polleck S; Liu H; Shi H; Rouse JC; Kim HY; Zhang Y; Gross ML
    Anal Chem; 2023 Nov; 95(46):16840-16849. PubMed ID: 37933954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. Unfolding, colloidal interactions, and formation of high-molecular-weight aggregates.
    Brummitt RK; Nesta DP; Chang L; Chase SF; Laue TM; Roberts CJ
    J Pharm Sci; 2011 Jun; 100(6):2087-103. PubMed ID: 21213308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What NMR can do in the biopharmaceutical industry.
    Kiss R; Fizil Á; Szántay C
    J Pharm Biomed Anal; 2018 Jan; 147():367-377. PubMed ID: 28760370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher Order Structure Characterization of Two Interdomain Disulfide Bond Variants of a Bispecific Monoclonal Antibody.
    Budyak IL; Huang L; Dukor RK
    J Pharm Sci; 2024 May; ():. PubMed ID: 38750935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.